Go offline with the Player FM app!
Adjuvant Therapy for Hepatocellular Carcinoma
Manage episode 475214115 series 2424442
Welcome to this week’s podcast by VJOncology, where we delve into the latest developments in adjuvant therapy for hepatocellular carcinoma. Join five leading experts as they discuss cutting-edge research and its impact on clinical practices.
Stephen Chan, MBBS, MRCP, The Chinese University of Hong Kong, Hong Kong, China, Laura Williams Goff, MD, MSCI, MMHC, Vanderbilt-Ingram Cancer Center, Nashville, TN, Lorenza Rimassa, MD, IRCCS Humanitas Research Hospital, Milan, Italy, Pierce Chow, MBBS, MMed (Surg), FRCS (Edin), FAMS (Gen Surg), PhD, National Cancer Centre Singapore & Duke-NUS Medical School Singapore, Singapore, and Ghassan Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, NY, break down the latest research, ongoing clinical trials, and what these developments mean for clinical practice. They touch on the promising results of the IMbrave150 and IMbrave050 trial, the Phase II study of regorafenib and pembrolizumab, the KEYSTEP-004 trial and future prospects for these adjuvant therapies.
The post Adjuvant Therapy for Hepatocellular Carcinoma appeared first on VJOncology.
196 episodes
Manage episode 475214115 series 2424442
Welcome to this week’s podcast by VJOncology, where we delve into the latest developments in adjuvant therapy for hepatocellular carcinoma. Join five leading experts as they discuss cutting-edge research and its impact on clinical practices.
Stephen Chan, MBBS, MRCP, The Chinese University of Hong Kong, Hong Kong, China, Laura Williams Goff, MD, MSCI, MMHC, Vanderbilt-Ingram Cancer Center, Nashville, TN, Lorenza Rimassa, MD, IRCCS Humanitas Research Hospital, Milan, Italy, Pierce Chow, MBBS, MMed (Surg), FRCS (Edin), FAMS (Gen Surg), PhD, National Cancer Centre Singapore & Duke-NUS Medical School Singapore, Singapore, and Ghassan Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, NY, break down the latest research, ongoing clinical trials, and what these developments mean for clinical practice. They touch on the promising results of the IMbrave150 and IMbrave050 trial, the Phase II study of regorafenib and pembrolizumab, the KEYSTEP-004 trial and future prospects for these adjuvant therapies.
The post Adjuvant Therapy for Hepatocellular Carcinoma appeared first on VJOncology.
196 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.